Unipower Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 14-12-2024
- Paid Up Capital ₹ 1.80 M
as on 14-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Unipower Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.80 M, as per Ministry of Corporate Affairs (MCA) records.
Parveen and Raghav Khurana serve as directors at the Company.
- CIN/LLPIN
U24231DL2015PTC278645
- Company No.
278645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Unipower Pharmaceuticals Private Limited offer?
Unipower Pharmaceuticals Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Common Disease Medicines, Pharmaceutical Syrup, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Diclofenac, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Unipower Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghav Khurana  | Director | 28-Sep-2021 | Current |
| Parveen | Director | 01-Apr-2015 | Current |
Financial Performance of Unipower Pharmaceuticals.
Unipower Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Unipower Pharmaceuticals?
In 2017, Unipower Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unipower Pharmaceuticals?
Unlock and access historical data on people associated with Unipower Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unipower Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unipower Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
